endocrinology
Type 1 diabetes

More evidence for CGM but funding remains a barrier

The federal government’s election promise of $54 million for continuous glucose monitoring (CGM) should not be limited to children and adolescents given the growing evidence for CGM in other patient populations, an expert says. Commenting on new research showing the benefits of CGM in adults with type 1 diabetes and impaired awareness of hypoglycaemia, paediatric ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic